Investigative therapy for melanoma promising


An investigative combination therapy combining chemotherapy and immunotherapy of adoptive cell transfer with tumor infiltrating lymphocytes, followed by interleukin-2, is labor-intensive but a feasible therapy with a high response rate in treated patients, according to researchers.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.